Dow Down 1.29% Nasdaq Down 3.25%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
1.12 Down 0.02(1.75%) Feb 5, 4:00PM EST
Prev Close:1.14
Open:1.13
Bid:0.90 x 10000
Ask:1.23 x 900
1y Target Est:5.28
Beta:0.401161
Next Earnings Date:N/A
Day's Range:1.12 - 1.16
52wk Range:0.80 - 2.94
Volume:765,997
Avg Vol (3m):1,686,240
Market Cap:315.61M
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICDown 1.75%315.61M
BMYDown 0.12%99.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.89
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.59
Quarterly EPS Est (Dec-15) :-0.07
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback